View in EDS HTML Full Text PDF Full Text

Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe® in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study.

Saved in:
Bibliographic Details
Title: Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe® in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study.
Authors: Balamurugan S; A.C.S Medical College and Hospital, Chennai, Tamil Nadu, India., Pophale H; Shreyas Hospital, Pune, Maharashtra, India., Samariya U; Chest Clinic, Uttar Pradesh, Varanasi, India., Apte K; Excellentia Consulting Services, Pune, Maharashtra, India., Singh S; Rajasthan Hospital, Jaipur, Rajasthan, India., Dhar R; CMRI CK Birla Hospital-Kolkata, Kolkata, West Bengal, India., Rajan S; Bhatia Hospital-Mumbai, Mumbai, Maharashtra, India., Swarnakar R; Getwell Hospital and Research Institute, Nagpur, Maharashtra, India., Talwar D; Metro Hospital and Heart Institute, New Delhi, Delhi, India., Lopez M; Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India., Naik V; Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India. Vaishali.naik@cipla.com., Sawant S; Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India., Chhowala S; Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India., Vaidya A; Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India., Gogtay J; Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2025 Dec; Vol. 12 (4), pp. 643-654. Date of Electronic Publication: 2025 Oct 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2199-1154
DOI:10.1007/s40801-025-00522-w